SEVERS DISEASE TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Severs Disease Treatment Market Size and Trends

The global Sever's Disease Treatment Market is estimated to be valued at USD 1.34 Bn in 2024 and is expected to reach USD 1.87 Bn by 2031, growing at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.

To learn more about this report, request sample copy

The market is witnessing positive growth trends due to rising incidences of Sever's disease worldwide, and increasing participation of kids and teenagers in sports activities is a key factor driving the market growth. Additionally, growing awareness regarding the treatment options for Sever's disease is also contributing towards the market growth. Various technological advancements in the area of Sever's disease diagnosis and treatment like advanced imaging techniques and minimally invasive treatment procedures are further expected to propel the demand for Sever's disease treatment over the forecast period. However, non-invasive treatment alternatives for Sever's disease like rest, ice, stretching, and heel raises offers first line treatment in mild cases which might hamper the market growth to some extent.

Rising incidence of Sever's disease

The incidence of Sever's disease, a common cause of heel pain in active children, has been on the rise globally in recent years. Sever's disease is caused by inversion or plantar flexion injuries of the growth plate in the heel bone. As more children participate in sports and recreational activities at an early age, the rate of repetitive microtrauma to the heel has increased significantly. According to United Nations Children's Fund (UNICEF) data from 2020, childhood obesity is also on the rise in both developed and developing nations due to sedentary lifestyles and poor diets. Obese children are four times more likely to develop Sever's disease due to increased stress on the heel and ankle joints. As the occurrence of Sever's disease rises, there is growing demand for effective treatment options. Non-steroidal anti-inflammatory drugs and heel cradles/supports are commonly used to manage symptoms in mild to moderate cases. For more severe cases, corticosteroid injections and physical therapy focusing on muscle strengthening and mechanics re-training are increasingly being utilized.

Increasing adoption of inorganic growth strategies, such as product launches, by key market players are expected to drive the market growth over the forecast period. For instance, in September 2020, Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, announced that it had launched Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren Arthritis Pain in the U.S. Diclofenac Sodium Topical Gel 1%, is used for the temporary relief of arthritis pain of the hand, wrist, elbow, foot, ankle, and knee.